InvestorsHub Logo
Followers 14
Posts 1733
Boards Moderated 0
Alias Born 04/07/2014

Re: None

Friday, 06/14/2024 10:57:10 AM

Friday, June 14, 2024 10:57:10 AM

Post# of 331791
If Biel’s product has been successfully blind-trial studied, and is a tried-and-true analgesic, then Biel should be in a great position to take advantage of the No Pain Act. Biel’s had more than enough time to get their ducks-in-a-row to be prepared to hit the ground running for something like this. With the Ambulatory Surgery services reimbursement being included in this act, one can only imagine what that could mean to Biel. Wow! If they are not able to take full advantage of this thing, then…“???????????????????????????”

My Goodness!
GLTA!!

P.S. Biel owes success to itself and its shareholders to get this RIGHT! The journey has been arduous